Techno Venture Management
95
12M
60
19
0.37
32
- Areas of investment
Summary
The leading representative office of defined VC is situated in the Boston. The company was established in North America in United States.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Techno Venture Management, startups are often financed by Birchmere Ventures, AlpInvest Partners, Draper Triangle. The meaningful sponsors for the fund in investment in the same round are AlpInvest Partners, Oxford Bioscience Partners, Venrock. In the next rounds fund is usually obtained by Thuja Capital, AlpInvest Partners, Amadeus Capital Partners.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the various public portfolio startups of the fund, we may underline Sirna Therapeutics, Addex Therapeutics, Ardana Bioscience Among the most successful fund investment fields, there are Health Care, Information Technology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. When startup sums 3 or 5+ of the founder, the probability for it to get the investment is little.
The overall number of key employees were 1.
Deals in the range of 10 - 50 millions dollars are the general things for fund. The top amount of exits for fund were in 2005. The high activity for fund was in 2001. Comparing to the other companies, this Techno Venture Management performs on 7 percentage points more the average number of lead investments. Considering the real fund results, this VC is 12 percentage points more often commits exit comparing to other organizations. When the investment is from Techno Venture Management the average startup value is 10-50 millions dollars. The fund is constantly included in 2-6 deals per year.
Investments analytics
Analytics
- Total investments
- 95
- Lead investments
- 19
- Exits
- 32
- Follow on index
- 0.37
- Investments by industry
- Biotechnology (54)
- Health Care (35)
- Pharmaceutical (28)
- Medical (24)
- Information Technology (15) Show 57 more
- Investments by region
-
- United States (50)
- Germany (26)
- United Kingdom (6)
- Switzerland (4)
- Austria (2) Show 3 more
- Peak activity year
- 2000
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 23
- Avg. valuation at time of investment
- 115M
- Group Appearance index
- 0.62
- Avg. company exit year
- 11
- Avg. multiplicator
- 2.80
- Strategy success index
- 0.70
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Addex Therapeutics | 17 May 2004 | Biotechnology, Health Care, Medical, Pharmaceutical | Early Stage Venture | 38M | Switzerland, Geneva |
Precision Therapeutics | 22 Feb 2006 | Health Care, Personal Health, Pharmaceutical, Clinical Trials | Early Stage Venture | 20M | United States, Pennsylvania, Pittsburgh |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.